The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. CorMedix Inc shares valued at $670,264 were sold by Zelnick Kaufman Beth on Sep 09 ’25. At $13.41 per share, Zelnick Kaufman Beth sold 50,000 shares. The insider’s holdings dropped to 180,418 shares worth approximately $2.36 million following the completion of this transaction.
Also, Hurlburt Elizabeth sold 41,121 shares, netting a total of over 537,863 in proceeds. Following the sale of shares at $13.08 each, the insider now holds 176,990 shares.
Before that, Hurlburt Elizabeth had sold 12,876 shares from its account. In a trade valued at $173,955, the Chief Operating Officer traded CorMedix Inc shares for $13.51 each. Upon closing the transaction, the insider’s holdings decreased to 12,876 shares, worth approximately $2.32 million.
As published in their initiating research note from H.C. Wainwright on June 30, 2025, CorMedix Inc [CRMD] has been a Buy and the price target has been revised to $20. Analysts at D. Boral Capital downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late June. As of March 07, 2025, Leerink Partners has initiated its “an Outperform” rating for CRMD. Earlier on January 13, 2025, D. Boral Capital initiated its rating. Their recommendation was “a Buy” for CRMD stock.
Analyzing CRMD Stock Performance
On last trading session, CorMedix Inc [NASDAQ: CRMD] rose 2.35% to $13.09. The stock’s lowest price that day was $12.8, but it reached a high of $13.3375 in the same session. During the last five days, there has been a surge of approximately 2.27%. Over the course of the year, CorMedix Inc shares have jumped approximately 133.75%. Shares of the company reached a 52-week high of $17.43 on 06/23/25 and a 52-week low of $5.60 on 04/07/25.
Support And Resistance Levels for CorMedix Inc (CRMD)
According to the 24-hour chart, there is a support level at 12.81, which, if violated, would cause prices to drop to 12.54. In the upper region, resistance lies at 13.35. The next price resistance is at 13.62. RSI (Relative Strength Index) is 51.17 on the 14-day chart, showing neutral technical sentiment.
Is CorMedix Inc subject to short interest?
Stocks of CorMedix Inc saw a sharp rise in short interest on 2025-08-29 jumping by 1.21 million shares to 11.89 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 10.68 million shares. A jump of 10.15% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.56 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.56.
Which companies own the most shares of CorMedix Inc (CRMD)?
In terms of CorMedix Inc share price expectations, FactSet research, analysts set an average price target of 17 in the next 12 months, up nearly 32.92% from the previous closing price of $12.79. Analysts anticipate CorMedix Inc stock to reach 17 by 2025, with the lowest price target being 17. In spite of this, 2 analysts ranked CorMedix Inc stock as Buy at the end of 2025. On August 26, 2024, Rodman & Renshaw assigned a price target of “a Buy” to the stock and initiated coverage with a $13.
